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Microarray Technique Identi®ed a New Pathogenetic Player in Cutaneous T Cell Lymphoma (CTCL)?
The microarray technique is a novel, very powerful tool to
generate molecular ``®ngerprints'' of various conditions and to
identify genes involved in diverse normal and pathologic
biologic processes. The principle of this technique consists of
a plate with probes of up to tens of thousands of genes
immobilized in an ordered manner (array). Messenger RNA
encoding proteins from biologic samples are reverse transcribed
into DNA, labeled, and then allowed to react with the
immobilized probes. In this way, the expression level of a large
number of genes (expression pattern, ``®ngerprint'') can be
determined on one plate and compared with plates from control
conditions. This technique has found application in many areas
of biomedical research, including cancer classi®cation. For
example, gene expression patterns in certain types of lymphoma
correspond well to their traditional classi®cation and prognosis.
Apart from the analysis of entire patterns, individual genes can
be identi®ed that are over- or underexpressed when compared
with a corresponding control condition. Such genes can then be
studied in more detail. Willers et al (p. 874) applied this
technique to identify genes that may be involved in CTCL.
They demonstrated that interferon inhibiting cytokine factor, a
cytokine identi®ed in 1994 that inhibits interferon-induced
expression of major histocompatibility (MHC) class II mole-
cules, was expressed at higher levels in cells from CTCL
patients than in normal CD4+ T cells. Next, the enhanced
expression of this cytokine in CTCL was con®rmed by another
method. Subsequently, the authors demonstrated that malignant
T cells from patients with SeÂzary syndrome, in contrast to
normal CD4+ T cells, did indeed not increase MHC class II
expression when stimulated with interferon, obviously a
consequence of increased interferon inhibiting cytokine factor
expression by the malignant T cells. Vice versa interferon
inhibiting cytokine factor was not modulated by interferon-g in
malignant T cells, unlike in healthy T cells. Interferon-g appears
to play a role in tumor surveillance because blocking of this
cytokine or deleting its receptor in experimental animal models
leads to enhanced tumor growth. Increased expression of
interferon inhibiting cytokine factor in CTLC may contribute
to the escape of malignant T cells from immune surveillance
and thus represent one of the many steps in the induction or
progression of CTCL.
Removal of Iron for the Treatment of Chronic Leg Ulcers?
Chronic leg ulcers in the majority of cases due to chronic
venous insuf®ciency represent a debilitating condition with
enormous individual and socio-economic impact. The normal
wound healing process appears to be de®cient in such lesions.
Wenk et al (p. 833) found that wound liquid from chronic
venous leg ulcers contained increased concentrations of iron.
Iron together with reactive oxygen species generated by
polymorphonuclear leukocytes in wounds creates a prooxidant
environment. The resulting effects include direct oxidative
damage to proteins, activation of metalloproteinases (collage-
nases) and other enzymes digesting extracellular matrix proteins,
and peroxidation of lipids that perpetuates the local in¯amma-
tory response and neutrophilic leukocyte attraction. These may
be important factors impeding the normal wound healing
process. In order to remove iron from the wounds, a wound
dressing with desferoxamine, an iron-binding molecule used for
the treatment of hemochromatosis, coupled to cellulose was
produced. The authors con®rmed that the dressing inhibited
iron-mediated oxidative activation of metalloproteinase 1 and
lipid peroxidation in vitro. Clinical studies with this dressing will
have to show whether this approach is successful for the
treatment of chronic leg ulcers. This will depend on the
importance of iron in impeding wound healing in chronic leg
ulcers.
The Cell Biology of Melanocyte Increase After Ultraviolet B Light Irradiation
It has been known for years that ultraviolet (UV) B light
stimulates the synthesis of melanin pigment in skin. In this
issue, Kawaguchi and Nakayama (p. 920) studied the response
of melanocytes to a single UV B-irradiation in a mouse model
(1.5 MED). Two weeks after irradiation the number of mature
melanocytes was signi®cantly increased. The authors investigated
the cell biology of this increase in melanocyte density. First, it
appears that division of differentiated melanocytes does not
explain the phenomenon. Mature epidermal melanocytes seem
to rather decrease in number, most likely by cell death.
Nonpigmented melanocyte precusor cells are recruited by UV
irradiation. These cells express Kit, a receptor for stem cell
factor or Kit ligand, and reside in the human in the lower half
of the follicular infundibulum. UV-irradiation induces the
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production of stem cell factor from keratinocytes. Stem cell
factor in turn stimulates the proliferation and differentiation of
Kit-expressing melanocyte precusor cells into melanoblasts. The
latter cells do not proliferate but further differentiate into
mature dendritically shaped melanocytes that can be detected
with the dopa reaction. The fact that inhibition of Kit function
by an antibody blocked the expected increase in mature
melanocytes hints to a critical role of stem factor and its
receptor in this UV response. It is possible that stem cell factor
or kit may become molecular targets for interfering positively or
negatively with this UV response and ultimately skin darkening
in response to sunlight exposure in humans.
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